Cargando…
Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Routine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is usually based on contrast-enhanced standard MRI. However, the capacity of standard MRI to differentiate neoplastic tissue from non-specific posttreatment effects may be limited particularly after ther...
Autores principales: | Galldiks, Norbert, Langen, Karl-Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963389/ https://www.ncbi.nlm.nih.gov/pubmed/27516754 http://dx.doi.org/10.3389/fneur.2016.00120 |
Ejemplares similares
-
Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017) -
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016) -
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
por: Werner, Jan-Michael, et al.
Publicado: (2020) -
Current status of PET imaging in neuro-oncology
por: Galldiks, Norbert, et al.
Publicado: (2019) -
Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)